Our diabetes publications 

Share this page...

About diabetes prevalence

Hsia Y, Neubert AC, Rani F, Viner RM, Hindmarsh PC, Wong IC.  An increase in the prevalence of type 1 and 2 diabetes in children and adolescents: results from prescription data from a UK general practice database.Br J ClinPharmacol.2009; 67: 242-9.

About living with diabetes

Christie,D., Martin,C. (Eds) Psychosocial Aspects of Diabetes. Children, Adolescents and their families, 2012. Radcliffe (London)

About transition

Christie D, Viner R.  Chronic illness and transition: time for action.Adolesc Med State Art Rev. 2009; 20: 981-7.

About education

Christie D, Strange V, Allen E, Oliver S, Wong IC, Smith F, Cairns J, Thompson R, Hindmarsh P, O'Neill S, Bull C, Viner R, Elbourne D.  Maximising engagement, motivation and long term change in a Structured Intensive Education Programme in Diabetes for children, young people and their families: Child and Adolescent Structured Competencies Approach to Diabetes Education (CASCADE).BMC Pediatr.2009; 9: 57.

About insulin pump therapy

Thompson, R. Adolescents and pump therapy – Maintaining success CSII therapy.  Diabetes Digest 2011 (Suppl); 10 :6-8

Thompson, R. Get going and stay going’ with pump therapy.Educating adolescents about pumps. Paediatrics and Child Health 2011; 21: 431-433

About Continuous Glucose Monitoring

Hammond PJ, Amiel SA, Dayan CM, Kerr D, Pickup JC, Shaw JAM, Campbell FM, Greene SA, Hindmarsh PC.  ABCD position statement on continuous glucose monitoring: use of glucose sensing in outpatient clinical diabetes care.  PractDiabInt 2010; 27: 66-8.

O'Riordan SM, Hindmarsh P, Hill NR, Matthews DR, George S, Greally P, Canny G, Slattery D, Murphy N, Roche E, Costigan C, Hoey H.  Validation Of Continuous Glucose Monitoring In Children And Adolescents With Cystic Fibrosis - A Prospective Cohort Study.Diabetes Care.2009; 32: 1020-1022.

About glucose fluctuation

Hill NR, Thompson B, Bruce J, Matthews DR, Hindmarsh P.  Glycaemic risk assessment in children and young people with Type 1 diabetes mellitus.Diabet Med. 2009; 26: 740-3.

Hill NR, Oliver NS, Choudhary P, Levy JC, Hindmarsh P, Matthews DR.  Normal Reference Range for Mean Tissue Glucose and Glycemic Variability Derived from Continuous Glucose Monitoring for Subjects Without Diabetes in Different Ethnic Groups.Diabetes TechnolTher.2011; 13: 921-8.

Sharma G, Muller D, O’Riordan S, Bryan S, Hindmarsh P, Dattani M, Mills K.  A novel method for the direct measurement of urinary conjugated metabolites of alpha-tocopherol and its use in diabetes.MolNutr Food Res 2010; 54: 599-600.

About different medications

Hsia Y, Dawoud D, Sutcliffe AG, Viner RM, Kinra S, Wong IC.  Unlicensed use of metformin in children and adolescents in the UK.Br J ClinPharmacol.2012; 73: 135-9.
Park MH, Kinra S, Ward KJ, White B, Viner RM.  Metformin for obesity in children and adolescents: a systematic review.Diabetes Care.2009; 32: 1743-5.

About other aspects of diabetes

Sharma G, Muller DP, O'Riordan SM, Bryan S, Dattani MT, Hindmarsh PC, Mills K.  Urinary conjugated α-tocopheronolactone - a biomarker of oxidative stress in children with type 1 diabetes.Free RadicBiol Med. 2013; 55: 54-62.

Thompson RJ, Agostini K, Potts L, Luscombe J, Christie D, Viner R, White B, Hindmarsh PC.  Deprivation and ethnicity impact on diabetes control and use of treatment regimen.Diabet Med. 2012 Sep 21. doi: 10.1111/dme.12023. [Epub ahead of print]

Prentice P, Viner RM.Pubertal timing and adult obesity and cardiometabolic risk in women and men: a systematic review and meta-analysis.Int J Obes 2012 Nov 20. doi: 10.1038/ijo.2012.177